Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.19B | 2.18B | 2.24B | 2.58B | 1.62B | 976.59M |
Gross Profit | 472.81M | 474.06M | 466.10M | 556.75M | 372.91M | 187.81M |
EBITDA | 165.08M | 169.82M | 161.86M | 343.35M | 184.79M | 90.02M |
Net Income | 39.93M | 46.48M | 36.05M | 128.67M | 103.14M | 28.03M |
Balance Sheet | ||||||
Total Assets | 1.47B | 1.40B | 1.23B | 1.43B | 1.11B | 459.52M |
Cash, Cash Equivalents and Short-Term Investments | 24.43M | 33.74M | 13.00M | 65.07M | 7.76M | 457.98K |
Total Debt | 673.53M | 623.07M | 564.03M | 789.86M | 570.59M | 166.61M |
Total Liabilities | 839.89M | 763.08M | 705.25M | 922.00M | 700.89M | 220.06M |
Stockholders Equity | 633.78M | 634.57M | 526.87M | 506.97M | 414.03M | 239.46M |
Cash Flow | ||||||
Free Cash Flow | 93.13M | 133.54M | 226.30M | 199.88M | -72.88M | 61.75M |
Operating Cash Flow | 103.28M | 142.75M | 238.08M | 210.69M | -65.42M | 64.19M |
Investing Cash Flow | -159.07M | -147.46M | -13.48M | -279.47M | -306.63M | ― |
Financing Cash Flow | 59.80M | 30.00M | -285.99M | 128.61M | 378.85M | ― |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | C$762.52M | 12.01 | 10.01% | 6.42% | 14.87% | -16.06% | |
73 Outperform | C$493.53M | 12.04 | 8.09% | 6.14% | -2.65% | -47.65% | |
71 Outperform | ¥255.26B | 12.94 | 8.49% | 3.09% | 6.34% | 12.95% | |
70 Neutral | $715.78M | 12.63 | 6.81% | 2.08% | 3.01% | 2.15% | |
69 Neutral | C$655.17M | 7.63 | 10.37% | 4.95% | -2.42% | -4.60% | |
55 Neutral | C$1.30B | ― | -9.26% | 3.69% | 1.70% | -154.73% | |
$1.82B | 16.69 | 9.30% | 3.91% | ― | ― |
ADENTRA Inc. reported first quarter 2025 sales of $542.5 million, marking a 1.4% increase from the previous year, despite challenges such as adverse weather and a softer residential construction market. The company maintained a stable gross margin of 21.6% and managed to offset a decline in organic sales with acquisition-based growth. ADENTRA is preparing for ongoing trade uncertainties by taking precautionary inventory measures and remains focused on maintaining its financial stability and shareholder returns.